Product Wiki · Recalls · Transport Canada Vehicle Recall Database

Recall 2026113 — ROLLS-ROYCE CULLINAN 2021-2024

Transport Canada Vehicle Recall Database · Canada · 2026-03-12

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
Transport Canada Vehicle Recall Database
Recall identifier
2026113
Date of alert
2026-03-12
Country / jurisdiction
Canada
Risk type
recall
Brand
ROLLS-ROYCE
Product category
SUV
Product type
Vehicle
Reported risk: Issue: On a small number of vehicles, the bolts that secure the left and right rear seat belts or the locking brackets for the rear bench seat backrest may not have been tightened properly. As a result, the bolts could loosen and damage the seat belt webbing(s). Additionally, loose cargo in the luggage compartment could contact and move the rear bench seat backrest in a crash. Safety Risk: A seat belt that doesn't work properly and/or a seat backrest that moves could create an increased risk of injury in a crash. Additionally, cargo that moves in a crash could create a risk of injury. Corrective Action: To reduce the safety risk, Rolls-Royce recommends not using the rear seats to transport passengers or carrying cargo in the luggage compartment until the recall repairs have been completed. Rolls-Royce will notify owners by mail and advise you to take your vehicle to a dealership to inspect and, if necessary, tighten or replace the bolts. Additionally, the dealer will inspect and, if necessary, replace the left and right rear seat belts.
Primary source: https://wwwapps.tc.gc.ca/Saf-Sec-Sur/7/VRDB-BDRV/search-recherche/detail.aspx?la

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.